Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 45,567 | 41,345 | 39,041 | 39,026 | 37,202 |
| Operating Income | -45,567 | -41,345 | -39,041 | -39,026 | -37,202 |
| Other Income | 3,714 | 4,391 | 4,972 | 5,708 | 6,277 |
| Pre-tax Income | -41,853 | -36,954 | -34,069 | -33,318 | -30,925 |
| Income Tax | 196 | 207 | 203 | 225 | 226 |
| Net Income Continuous | -42,049 | -37,161 | -34,272 | -33,543 | -31,151 |
| Net Income | $-42,049 | $-37,161 | $-34,272 | $-33,543 | $-31,151 |
| EPS Basic Total Ops | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 |
| EPS Basic Continuous Ops | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 |
| EPS Diluted Total Ops | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 |
| EPS Diluted Continuous Ops | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.44 | -0.40 | -0.40 | -0.37 |
| EBITDA(a) | $-46,538 | $-42,562 | $-40,677 | $-41,635 | $-39,694 |